Understanding the Structure of Module 2.7: Clinical Summary Simplified

agregó una foto Health

2025-07-01 06:14:55 -

In medicinal Product (drug) development and Regulatory submissions, one component that can significantly influence the speed and success of approval is the Clinical Summary—or Module 2.7—within the Common Technical Document (CTD). Whether you're submitting a New Drug Application (NDA) to the FDA, a Marketing Authorization Application (MAA) to the EMA, or a Global Dossier under ICH...

0 Commentarios 0 Acciones 909 Views 0 Vista previa